Evidence map›Paper›PMID 39331310›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2024

First whole genome sequencing and analysis of human parechovirus type 3 causing a healthcare-associated outbreak among neonates in Hungary.

Nóra Deézsi-Magyar, Nikolett Novák, Adrienne Lukács, Katalin Réka Tarcsai, Ágnes Hajdu, László Takács, Ferenc Balázs Farkas, Zita Rigó, Erzsébet Barcsay, Zoltán Kis and 1 more

Abstract read
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nóra Deézsi-MagyarDepartment of Microbiological Reference Laboratories, National Center for Public Health and Pharmacy, Albert Flórián Rd. 2-6. 1097, Budapest, Hungary.
Nikolett NovákDepartment of Microbiological Reference Laboratories, National Center for Public Health and Pharmacy, Albert Flórián Rd. 2-6. 1097, Budapest, Hungary.
Adrienne LukácsDepartment of Microbiological Reference Laboratories, National Center for Public Health and Pharmacy, Albert Flórián Rd. 2-6. 1097, Budapest, Hungary.
Katalin Réka TarcsaiDepartment of Microbiological Reference Laboratories, National Center for Public Health and Pharmacy, Albert Flórián Rd. 2-6. 1097, Budapest, Hungary.
Ágnes HajduDepartment of Communicable Disease Epidemiology and Infection Control, National Center for Public Health and Pharmacy, Budapest, Hungary.
László TakácsBethesda Children Hospital, Budapest, Hungary.
Ferenc Balázs FarkasPediatric Center, Semmelweis University, Budapest, Hungary.
Zita RigóDepartment of Microbiological Reference Laboratories, National Center for Public Health and Pharmacy, Albert Flórián Rd. 2-6. 1097, Budapest, Hungary.
Erzsébet BarcsayDepartment of Microbiological Reference Laboratories, National Center for Public Health and Pharmacy, Albert Flórián Rd. 2-6. 1097, Budapest, Hungary.
Zoltán KisDepartment of Microbiological Reference Laboratories, National Center for Public Health and Pharmacy, Albert Flórián Rd. 2-6. 1097, Budapest, Hungary. kis.zoltan@semmelweis.hu.
Katalin SzomorDepartment of Microbiological Reference Laboratories, National Center for Public Health and Pharmacy, Albert Flórián Rd. 2-6. 1097, Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn November 2023, the National Reference Laboratory for Enteroviruses (Budapest, Hungary) received stool, pharyngeal swab and cerebrospinal fluid samples from five newborns suspected of having human parechovirus (PEV-A) infection. The neonates were born in the same hospital and presented with fever and sepsis-like symptoms at 8-9 days of age, and three of them showed symptoms consistent with central nervous system involvement. PEV-A positivity was confirmed by quantitative reverse transcription polymerase chain reaction.

methodsTo determine the PEV-A genotype responsible for the infections, fecal samples of four neonates were subjected to metagenomic sequencing. For further analyses, amplicon-based whole genome sequencing was performed directly from the clinical samples.

resultsOn the basis of whole genome analysis, sequences were allocated to PEV-A genotype 3 (PEV-A3) and consensus sequences were identical. Two ambiguities were identified in the viral protein 1 (VP1) region of all sequences at a frequency of 17.7-53.7%, indicating the simultaneous presence of at least two quasispecies in the clinical samples. The phylogenetic analysis and similarity plotting showed that all sequences clustered without any topological inconsistencies between the P1 capsid and P2, P3 non-capsid regions, suggesting that recombination events during evolution were unlikely.

conclusionOur findings suggest that the apparent cluster of cases were microbiologically related, and the results may also inform future investigations on the evolution and pathogenicity of PEV-A3 infections.

Indexed as

Disease OutbreaksGenome, ViralGenotypeParechovirusPhylogenyPicornaviridae InfectionsWhole Genome SequencingCross InfectionFecesFemaleHumansHungaryInfant, NewbornMaleGenotypingHuman parechovirus 3Infection of neonatesPhylogenetic analysisWhole genome sequencing

Identifiers

PMID39331310
PMCPMC11608160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.